title: Anti-CD3 antibodies for type 1 diabetes: beyond expectations.
authors: Université Paris Descartes, Paris, France. jean-francois.bach@academie-sciences.fr
authors: Jean-François
authors: JF
authors: Bach
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D017252:CD3 Complex / Q000187:drug effects* / Q000276:immunology; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007004:Hypoglycemic Agents / Q000276:immunology / Q000627:therapeutic use*; D016853:Muromonab-CD3 / Q000008:administration & dosage / Q000276:immunology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D017252:CD3 Complex; D007004:Hypoglycemic Agents; D016853:Muromonab-CD3; C550701:otelixizumab; C502540:teplizumab